Pharmaceutical Regulatory Affairs: Open Access

Department of Biology, Carleton University, Ottawa, ON K1S 5B6, Canada

Publications

• Mini Review   
  Harnessing Plant Platforms for Innovative Monoclonal Antibody Production in Veterinary Medicine
  Author(s): Lippert Kanfer*
  
  The production of monoclonal antibodies (mAbs) has revolutionized medical treatments across human and veterinary fields, offering precise and effective therapies for a range of conditions. Traditional methods of mAb production involve mammalian cell lines, which, while effective, are costly and complex. Recent advancements in plant biotechnology have introduced a novel and cost-effective alternative: plant-based platforms for mAb production. This article explores the potential of harnessing plant platforms for the production of mAbs in veterinary medicine, detailing the mechanisms, advantages, and challenges associated with this innovative approach. Plant-based systems offer several benefits, including reduced production costs, enhanced safety profiles, and scalability. However, challenges such as regulatory hurdles and plant-specific glycosylation patterns mus.. Read More»
  DOI: 10.37421/2167-7689.2024.13.430

  Abstract HTML PDF